D. E. Shaw & Co., Inc. Adaptive Biotechnologies Corp Transaction History

D. E. Shaw & Co., Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$3.46 - $5.33 $309,759 - $477,173	-89,526 Reduced 68.2%	41,743 $204,000
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $219,637 - $365,629	43,321 Added 49.26%	131,269 $715,000
Q2 2023 Aug 14, 2023	SELL	$6.19 - $8.78 $865,244 - $1.23 Million	-139,781 Reduced 61.38%	87,948 $590,000
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $870,066 - $1.13 Million	111,547 Added 96.01%	227,729 $2.01 Million
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $359,937 - $537,031	57,498 Added 97.98%	116,182 $887,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $633,750 - $1.24 Million	-97,500 Reduced 62.43%	58,684 $418,000
Q2 2022 Aug 15, 2022	BUY	$6.4 - $14.73 $153,478 - $353,240	23,981 Added 18.14%	156,184 $1.26 Million
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $1.34 Million - $3.82 Million	132,203 New	132,203 $1.84 Million
Q3 2020 Nov 16, 2020	SELL	$35.79 - $48.81 $682,443 - $930,709	-19,068 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $475,746 - $922,509	19,068 New	19,068 $923,000
Q1 2020 May 15, 2020	SELL	$16.96 - $34.16 $465,653 - $937,896	-27,456 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $674,319 - $900,556	27,456 New	27,456 $821,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.